India has sold more than 3.5 billion anti-fever medications since the emergence of COVID-19 in 2020. In the last two years, sales of this oval-shaped white pill have tripled.
If all Dolo tablets sold in India during the pandemic were stacked together it is almost 6,000 times as tall as Mount Everest, the world’s highest mountain peak, or nearly 63,000 times as high as the world’s tallest building Burj Khalifa. Before the COVID-19 pandemic in 2019, India supplied approximately 75 million strips of Dolo pills or 1.4 billion tablets.
The first wave of COVID-19 arrived in India in September 2020, while the second wave came in May 2021, causing the most deaths. More than 350 crore Dolo pills were marketed throughout both epidemic years. It has climbed to 145 million strips (twice as much as in 2019), or 2.2 billion pills by November 2021. With sales of Rs 3.1 billion in 2021, Dolo is India’s second-most popular anti-fever and painkiller pill.